Pseudoxanthoma Elasticum (PXE) is a rare genetic disorder that affects the connective tissues in the body. It primarily affects the skin, eyes, and blood vessels.
PXE is characterized by the abnormal mineralization and fragmentation of elastic fibers, which are responsible for providing elasticity to various tissues. As a result, affected individuals may experience progressive changes in their skin, such as yellowish bumps or plaques, particularly in areas exposed to the sun. These skin abnormalities can also be found in other body parts, including the eyes, where they may lead to vision problems.
Furthermore, PXE can affect blood vessels, leading to complications such as calcification and narrowing. This can result in reduced blood flow to vital organs, potentially causing cardiovascular issues or gastrointestinal bleeding.
Although PXE is a genetic condition, its symptoms and severity can vary widely among individuals. It is typically diagnosed through a combination of clinical evaluation, skin biopsy, and genetic testing.
While there is currently no cure for PXE, treatment focuses on managing symptoms and preventing complications. Regular monitoring by healthcare professionals is crucial to address any potential issues promptly.